• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2018 年兰利奖基础尼古丁与烟草研究奖:将精准医学应用于戒烟。

2018 Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation.

机构信息

Department of Psychiatry, Washington University School of Medicine, St. Louis, MO.

出版信息

Nicotine Tob Res. 2020 Feb 6;22(2):147-151. doi: 10.1093/ntr/ntz036.

DOI:10.1093/ntr/ntz036
PMID:30855677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7161927/
Abstract

INTRODUCTION

Large segments of the world population use combustible cigarettes, and our society pays a high price for smoking, through increased healthcare expenditures, morbidity and mortality. The development of combustible cigarette smoking requires the initiation of smoking and a subsequent chain of behavioral transitions from experimental use, to established regular use, to the conversion to addiction. Each transition is influenced by both environmental and genetic factors, and our increasing knowledge about genetic contributions to smoking behaviors opens new potential interventions.

METHODS

This review describes the journey from genetic discovery to the potential implementation of genetic knowledge for the treatment of tobacco use disorder.

RESULTS AND CONCLUSIONS

The field of genetics applied to smoking behaviors has rapidly progressed with the identification of highly validated genetic variants that are associated with different smoking behaviors. The large scale implementation of this genetic knowledge to accelerate smoking cessation represents an important clinical challenge in precision medicine.

摘要

简介

世界上很大一部分人口使用可燃香烟,我们的社会为吸烟付出了高昂的代价,包括增加医疗保健支出、发病率和死亡率。可燃香烟的发展需要吸烟的开始,以及随后从实验使用、到既定的定期使用、再到成瘾的行为转变的链条。每个转变都受到环境和遗传因素的影响,我们对遗传因素对吸烟行为的贡献的认识不断增加,为新的潜在干预措施开辟了道路。

方法

本综述描述了从遗传发现到潜在实施遗传知识治疗烟草使用障碍的过程。

结果和结论

应用于吸烟行为的遗传学领域取得了快速进展,已经确定了与不同吸烟行为相关的高度验证的遗传变异。大规模实施这种遗传知识以加速戒烟是精准医学面临的一个重要临床挑战。

相似文献

1
2018 Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation.2018 年兰利奖基础尼古丁与烟草研究奖:将精准医学应用于戒烟。
Nicotine Tob Res. 2020 Feb 6;22(2):147-151. doi: 10.1093/ntr/ntz036.
2
Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How.利用精准医学时代的基因组数据进行戒烟临床试验:原因与方法。
Nicotine Tob Res. 2018 Mar 6;20(4):414-424. doi: 10.1093/ntr/ntx097.
3
Estimating Demand and Cross-Price Elasticity for Very Low Nicotine Content (VLNC) Cigarettes Using a Simulated Demand Task.利用模拟需求任务估计极低尼古丁含量 (VLNC) 香烟的需求和交叉价格弹性。
Nicotine Tob Res. 2018 Jun 7;20(7):843-850. doi: 10.1093/ntr/ntx051.
4
Smokers' Understandings of Addiction to Nicotine and Tobacco: A Systematic Review and Interpretive Synthesis of Quantitative and Qualitative Research.烟民对尼古丁和烟草成瘾的理解:定量和定性研究的系统评价和解释性综合。
Nicotine Tob Res. 2018 Aug 14;20(9):1038-1046. doi: 10.1093/ntr/ntx186.
5
Toward precision smoking cessation treatment I: Moderator results from a factorial experiment.迈向精准戒烟治疗 I:析因实验的调节变量结果
Drug Alcohol Depend. 2017 Feb 1;171:59-65. doi: 10.1016/j.drugalcdep.2016.11.025. Epub 2016 Nov 25.
6
Pathways to precision medicine in smoking cessation treatments.戒烟治疗中的精准医学路径。
Neurosci Lett. 2018 Mar 16;669:83-92. doi: 10.1016/j.neulet.2016.05.033. Epub 2016 May 18.
7
Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.烟草依赖的精准医学:尼古丁代谢物比率的开发与验证
J Neuroimmune Pharmacol. 2016 Sep;11(3):471-83. doi: 10.1007/s11481-016-9656-y. Epub 2016 Feb 12.
8
Neurogenetic determinants and mechanisms of addiction to nicotine and smoked tobacco.尼古丁和吸烟成瘾的神经遗传学决定因素及机制
Eur J Neurosci. 2019 Aug;50(3):2164-2179. doi: 10.1111/ejn.14171. Epub 2018 Oct 25.
9
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
10
A glimpse into the future - Personalized medicine for smoking cessation.展望未来——个性化戒烟医学。
Neuropharmacology. 2014 Jan;76 Pt B(0 0):592-9. doi: 10.1016/j.neuropharm.2013.09.009. Epub 2013 Sep 18.

引用本文的文献

1
Individual variations in motives for nicotine self-administration in male rats: evidence in support for a precision psychopharmacology.雄性大鼠尼古丁自我给药动机的个体差异:支持精准精神药理学的证据。
Transl Psychiatry. 2024 Feb 9;14(1):85. doi: 10.1038/s41398-024-02774-6.
2
Advancing Biomarkers for Treatment of Smoking and Nicotine Dependence: An Overview.用于治疗吸烟和尼古丁依赖的生物标志物进展:概述
Addict Neurosci. 2023 Dec;8. doi: 10.1016/j.addicn.2023.100117. Epub 2023 Jul 8.
3
The use of biomarkers to guide precision treatment for tobacco use.使用生物标志物指导烟草使用的精准治疗。
Addict Neurosci. 2023 Jun;6. doi: 10.1016/j.addicn.2023.100076. Epub 2023 Feb 16.
4
The relationship between endoplasmic reticulum stress and autophagy in apoptosis of BEAS-2B cells induced by cigarette smoke condensate.香烟烟雾冷凝物诱导BEAS-2B细胞凋亡过程中内质网应激与自噬的关系
Toxicol Res (Camb). 2021 Jan 5;10(1):18-28. doi: 10.1093/toxres/tfaa095. eCollection 2021 Jan.
5
Proof of Concept of a Personalized Genetic Risk Tool to Promote Smoking Cessation: High Acceptability and Reduced Cigarette Smoking.促进戒烟的个性化遗传风险工具的概念验证:高接受度和减少吸烟。
Cancer Prev Res (Phila). 2021 Feb;14(2):253-262. doi: 10.1158/1940-6207.CAPR-20-0328. Epub 2020 Sep 21.

本文引用的文献

1
Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use.对多达 120 万人的关联研究为烟草和酒精使用的遗传病因学提供了新的见解。
Nat Genet. 2019 Feb;51(2):237-244. doi: 10.1038/s41588-018-0307-5. Epub 2019 Jan 14.
2
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.戒烟的药物治疗:基于基因信息生物标志物定义的亚组的效果
Cochrane Database Syst Rev. 2017 Sep 8;9(9):CD011823. doi: 10.1002/14651858.CD011823.pub2.
3
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.大规模关联分析确定了新的肺癌易感位点以及不同组织学亚型遗传易感性的异质性。
Nat Genet. 2017 Jul;49(7):1126-1132. doi: 10.1038/ng.3892. Epub 2017 Jun 12.
4
The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog).新的NHGRI-EBI已发表全基因组关联研究目录(GWAS目录)。
Nucleic Acids Res. 2017 Jan 4;45(D1):D896-D901. doi: 10.1093/nar/gkw1133. Epub 2016 Nov 29.
5
Variants near CHRNA3/5 and APOE have age- and sex-related effects on human lifespan.CHRNA3/5和APOE附近的变异对人类寿命有与年龄和性别相关的影响。
Nat Commun. 2016 Mar 31;7:11174. doi: 10.1038/ncomms11174.
6
Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans.CHRNA5基因中的罕见、低频和常见编码变异及其对欧洲裔和非裔美国人尼古丁依赖的影响。
Mol Psychiatry. 2016 May;21(5):601-7. doi: 10.1038/mp.2015.105. Epub 2015 Aug 4.
7
Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons.烟碱型α5亚基变体在腹侧中脑神经元Ca2+通量中的关键作用。
FASEB J. 2015 Aug;29(8):3389-98. doi: 10.1096/fj.14-268102. Epub 2015 Apr 24.
8
CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.CHRNA5风险变异预测戒烟延迟和肺癌早期诊断——一项荟萃分析。
J Natl Cancer Inst. 2015 Apr 14;107(5). doi: 10.1093/jnci/djv100. Print 2015 May.
9
Role of α5* nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice.α5*烟碱型乙酰胆碱受体在急性和慢性尼古丁处理对小鼠脑奖赏功能影响中的作用
Psychopharmacology (Berl). 2013 Aug 20. doi: 10.1007/s00213-013-3235-1.
10
Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by α3β4α5 nicotinic acetylcholine receptors.人类 D398N 单核苷酸多态性对 α3β4α5 烟碱型乙酰胆碱受体介导的细胞内钙反应的影响。
Neuropharmacology. 2012 Nov;63(6):1002-11. doi: 10.1016/j.neuropharm.2012.07.022. Epub 2012 Jul 20.